13 results about "Harpagoside" patented technology

The invention relates to a traditional Chinese medicine composition which comprises active ingredients extracted from astragalus membranaceus, angelica sinensis, codonopsis pilosula, radix scrophulariae, dendrobe, radix achyranthis bidentatae, honeysuckle and liquorice, and the active ingredients comprise the following components in percentage by mass: more than 0.8 permillage of neochlorogenic acid, more than 1.8 permillage of chlorogenic acid, more than 1.0 permillage of cryptochlorogenic acid, more than 0.50 permillage of isochlorogenic acid A, more than 0.60 permillage of isochlorogenic acid B and more than 0.80 permillage of isochlorogenic acid C, the medicine is prepared from the following raw materials in percentage by weight: more than 1.1 per mill of secoxyloganin, more than 3.5 per mill of glycyrrhizic acid, more than 1.3 per mill of liquiritin, more than 0.25 per mill of harpagoside, more than 0.15 per mill of beta-ecdysterone, more than 0.8 per mill of astragaloside, more than 0.14 per mill of ginsenoside RO, more than 0.1 per mill of senkyunolide A and more than 0.1 per mill of lobetyolin. The method can be used for quality control of the traditional Chinese medicine composition, so that stable quality and reliable curative effect of the traditional Chinese medicine preparation are ensured.

The invention belongs to the field of quality analysis of traditional Chinese medicines, and particularly discloses a method for determining the content of iridoid components, which adopts HPLC (High Performance Liquid Chromatography) to simultaneously determine the contents of six iridoid components, namely morroniside, geniposide, loganin, picroside II, picroside I and harpagoside, in four medicinal materials, namely dogwood, cape jasmine, picrorhiza scrophularia and radix scrophulariae. According to the method, the content of iridoid components in multiple medicinal materials can be measured, the detection cost is reduced, the detection time is shortened, and the detection efficiency is improved. The detection method provided by the invention is stable and reliable, has the advantages of strong specificity, good reproducibility and the like, can ensure the safety and effectiveness of clinical medication of common medicinal materials such as dogwood, cape jasmine, rhizoma picrorhizae, radix scrophulariae and the like, and better meets the medical and market requirements.

The present invention discloses a method for simultaneously detecting seven effective ingredients in Yangyin Qingfei Pills, and belongs to the technical field of chemical detection. The method for simultaneously detecting seven effective ingredients in Yangyin Qingfei Pills described in the present invention comprises the following steps: injecting the Yangyin Qingfei Pill sample solution into a liquid chromatograph, and using a segmented wavelength conversion method to perform chromatographic detection to achieve qualitative and quantitative detection of the seven effective ingredients. The present invention uses the UPLC segmented wavelength conversion method to achieve simultaneous determination of the contents of harpagine, paeoniflorin, liquiritin, verbascoside, harpagine, paeonol and glycyrrhizic acid in Yangyin Qingfei Pills, and all seven effective ingredients can be well separated without interference from other ingredients. Moreover, each component has a good linear relationship within its own linear range, and the sample recovery rate is between 95% and 105%. The detection method of the present invention is simple, accurate and effective, and can be used for quality control and overall quality evaluation of Yangyin Qingfei Pills.

The invention discloses an application of harpagoside in preparation of a low-temperature preservation solution of a biological material. On the first aspect, the invention provides application of harpagoside, a stereoisomer thereof or pharmaceutically acceptable ester thereof in preparation of a low-temperature preserving fluid for biological materials. The harpagoside component can effectively improve the preservation effect of the biological material at low temperature and prolong the preservation time.

The application discloses a crocus rhizosphere microorganism and application thereof, and belongs to the technical field of traditional Chinese medicinal material quality and quality improvement. The rhizosphere microorganism is obtained by using traditional bacterial separation and purification technology from a crocus rhodora plant crocus living body, belongs to the actinobacteria phylum, mycobacterium order, mycobacterium family and mycolicibacterium genus bacteria, is classified and named as (Mycolicibacterium frederiksbergense) SRB560, and the strain preservation number is CGMCC No. 29735. The application also discloses the application of the rhizosphere microorganism. The rhizosphere microorganism can effectively promote the growth and effective component content accumulation of radix scrophulariae, improves the medicinal material yield by 50.08% (P<0.05), and improves the total amount of harpagide and harpagoside by 25.56% (P<0.05). The rhizosphere microorganism has obvious effects on promoting the growth of radix scrophulariae and improving the quality of radix scrophulariae, and brings wide application prospects for the development of the radix scrophulariae industry.

The invention belongs to the field of analysis of traditional Chinese medicine preparations, and particularly discloses a method for detecting the content of multiple components in herba inulae and caulis lonicerae particles for clearing arthralgia. According to the content detection method, the content of 11 components including sinomenine, neochlorogenic acid, magnoflorine, cryptochlorogenic acid, chlorogenic acid, isochlorogenic acid B, isochlorogenic acid A, isochlorogenic acid C, harpagoside, ligustilide and ammonium glycyrrhizinate in the preparation is determined by adopting an HPLC (High Performance Liquid Chromatography) multi-wavelength switching method. The quality detection method disclosed by the invention is stable, reliable, high in specificity and good in reproducibility, can be used for comprehensively and effectively controlling the quality of the herba inulae arthralgia clearing granules, and is beneficial to stabilizing the product quality and ensuring the safety and effectiveness of clinical medication, so that the requirements of medical treatment and markets are better met.

This invention relates to the field of molecular biology technology of medicinal plants, and particularly to a protein, gene, and their application related to the biosynthesis of harpagoside in Scrophularia ningpoensis. The proteins disclosed in this invention related to the biosynthesis of harpagoside in Scrophularia ningpoensis include the Sni_B_54755.0 protein shown in SEQ ID NO.1; the Sni_B_54755.1 protein shown in SEQ ID NO.3; or the Sni_B_54755.9 protein shown in SEQ ID NO.5. In vitro and in vivo enzyme activity verification, UPLC and LC-MS product identification of these proteins confirmed that the above three proteins are related to the biosynthesis of harpagoside in Scrophularia ningpoensis. This provides a basis for the analysis of key enzymes in the biosynthesis of harpagoside in Scrophularia ningpoensis, the discovery of related functional genes, and metabolic engineering research.

The invention discloses an application of harpagoside in preparation of a medicine for preventing ionizing radiation injury. Research finds that ionizing radiation can cause zebrafish embryonic dysplasia, hematopoietic dysfunction and low athletic ability, and harpagoside can effectively prevent and treat the conditions. The research results indicate that the harpagoside is a novel way for preventing and treating ionizing radiation damage.

The invention relates to a method for extracting a magic grass extract, in particular to a method for extracting harpagoside from magic grass, and aims to overcome the defect of long process period in the existing technology for extracting harpagoside. The method comprises the steps of raw material crushing and enzymolysis, organic solvent impurity removal, extraction, graded sedimentation, membrane separation, membrane concentration, extraction, crystallization and the like, the whole preparation process is mild in condition, the loss of the harpagoside under a high heat condition is avoided, the influence of temperature on the instability of the harpagoside is effectively avoided, and the method is suitable for industrial production. The activity and the purity of the harpagoside can be maintained, and the harpagoside with relatively high quality can be obtained.

The invention discloses a UHPLC-MS / MS (Ultra High Performance Liquid Chromatography-Mass Spectrometry / Mass Spectrometry)-based multi-component content determination method for a compound radix scutellariae throat-clearing capsule, which is characterized in that a multi-component simultaneous quantitative analysis method is established by adopting a UHPLC-MS / MS technology, and the quality of the compound radix scutellariae throat-clearing capsule is evaluated from the quantitative aspect. 21 components including p-hydroxybenzaldehyde, vanillin, caffeic acid, syringaldehyde, citric acid, tanshinol, chrysin, baicalein, genistein, quercetin, chlorogenic acid, neochlorogenic acid, rosmarinic acid, harpagide, puerarin, apigenin-7-O-beta-D-glucoside, baicalin, oleanolic acid, scutellarin, glycyrrhetinic acid and harpagoside are selected as quantitative indexes; and determining the content of the compound radix scutellariae throat-clearing capsule. According to the method, the contents of 21 components in the compound radix scutellariae throat-clearing capsule can be accurately measured at the same time within 14 min, and the method has good precision and stability.

This invention relates to the field of analytical detection technology, and particularly to the application of harpagoside or harpagoside in the identification of Scrophularia ningpoensis honey. This invention is the first to discover that harpagoside and harpagoside can serve as characteristic marker compounds for the identification of Scrophularia ningpoensis honey. Furthermore, this invention provides a method for identifying Scrophularia ningpoensis honey, which exhibits high specificity and sensitivity, with a detection limit of 5–20 μg / kg for the target compound, an accuracy between 87–108%, and a coefficient of variation of less than 15%. The identification method of this invention is simple to operate, highly efficient, and easy to promote and apply. It is of great significance for the identification and authenticity evaluation of Scrophularia ningpoensis honey and has broad application prospects.

The invention relates to a preparation method of harpagoside, and belongs to the technical field of natural product extraction. The method comprises the following steps: extracting uncaria gramineus with an extraction solvent to obtain a crude extract; the crude extract is sequentially subjected to extraction with an extraction solution, column separation and crystallization, and harpagoside is obtained, the extraction liquid is n-butyl alcohol. By optimizing the extraction conditions and the extraction method, the extraction efficiency and the purity of the harpagoside are remarkably improved. In addition, a special filler adopted in the column separation step can effectively improve the separation effect of a target compound, so that the finally obtained harpagoside has higher purity and better stability. The method not only is simple and convenient to operate, but also has good repeatability, and is suitable for the requirements of industrial production.

The invention discloses a saffron rhizosphere microorganism and application thereof, and belongs to the technical field of quality and quality improvement of traditional Chinese medicinal materials. The rhizosphere microorganism is separated from a crocus sativus living body of an orris crocus plant by adopting a traditional bacterium separation and purification technology, belongs to bacteria of actinomycetes, mycobacteria, mycobacteriaceae and mycobacterial actinomycetes, and is classified and named as (Mycolicbacteria frederiksbergense) SRB560, and the preservation number of the strain is CGMCC (China General Microbiological Culture Collection Center) No.29735. The invention further discloses a preparation method of the rhizosphere microorganism. The rhizosphere microorganism can effectively promote the growth of radix scrophulariae and the accumulation of the content of effective components, and the yield of medicinal materials is increased by 50.08% (Plt; 0.05), the total amount of harpagide and harpagoside is increased by 25.56% (Plt; 0.05) of the method. The rhizosphere microorganism has obvious effects of promoting the growth of the radix scrophulariae and improving the quality of the radix scrophulariae medicinal material, and brings a wide application prospect for the industrial development of the radix scrophulariae.